Tofacitinib


( Last Updated : May 5, 2014)
Generic Name:
Tofacitinib
Project Status:
Complete
Therapeutic Area:
Arthritis, rheumatoid
Manufacturer:
Pfizer Canada Inc.
Call for patient/clinician input open:
Brand Name:
Xeljanz
Project Line:
Reimbursement Review
Project Number:
SR0380-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Arthritis, Rheumatoid
Recommendation Type:
List with criteria/condition
Final Recommendation: